mazindol has been researched along with Adrenal Cancer in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naoi, M | 1 |
| Takahashi, T | 1 |
| Ichinose, H | 1 |
| Wakabayashi, K | 1 |
| Sugimura, T | 1 |
| Nagatsu, T | 1 |
1 other study available for mazindol and Adrenal Cancer
| Article | Year |
|---|---|
Uptake of heterocyclic amines, Trp-P-1 and Trp-P-2, into clonal rat pheochromocytoma PC12h cells by dopamine uptake system.
Topics: Adrenal Gland Neoplasms; Animals; Carbolines; Chromatography, High Pressure Liquid; Dopamine; Kineti | 1989 |